more News
Dr. Kaiser J. Aziz, former FDA Director, Division Mechanics and Materials Science, joins ARV Excellence
ARV Excellence is delighted to announce that Dr. Kaiser J. Aziz has joined ARV Excellence as Senior Consultant for Clinical Science and Regulatory Affairs. Dr. Aziz's expertise includes FDA's Quality System Compliance, Assessment of Applied Clinical Research and Product Development; Guidance for Protocols for Pre-Clinical and Clinical Studies for U.S. Premarket Approval Process.
Dr. Aziz completed a 29-year career with FDA. Kaiser was Director, Division of Mechanics and Materials Science – FDA, Assoc. Director, Clinical Lab Devices – FDA, and Chief, Clinical Chemistry, Hematology, and Pathology – FDA. Dr. Aziz had a distinguished career as a clinical regulatory scientist and manager of drug and device evaluations, approvals, reengineering, standards, good manufacturing and quality system applications. During his career Dr. Aziz worked with individual and industry organizations in design and total product life cycle (TPLC) approaches to premarket applications for medical devices, pharmaceuticals and combination products. He has received numerous awards including an award from the Vice President of the United States, Al Gore for his work on QSIT. During his tenure with the FDA Dr. Aziz served as an adjunct faculty in the Department of Medicine and Physiology, NIH Graduate School, where he developed and taught courses and workshops in Medical Devices and Clinical Laboratory Medicine. Currently, he serves as an adjunct faculty at the Center for Applied Health Sciences, Virginia Polytechnic Institute and State University, where he teaches medical device and pharmaceutical risk management courses and workshops. He has published numerous scientific and regulatory articles in professional and trade journals, and he has published several individual Text Book Chapters. He is a fellow of the National Academy of Clinical Biochemistry and Association of Clinical Scientists. He is certified as a Clinical Laboratory Director by the American Board of Bioanalysis. He serves as a member of editorial advisory boards of professional journals. He was an invited guest editor on Nanotechnology and Clinical Trials in the Journal of Clinical Ligand Assay in 2006.
© 2008 ARV Excellence Ltd.
more News
Repeatable Inspections. A Pragmatic Service....
read more»IBEC's Pharmachemical Ireland host Quality By Design: A Systematic Approach to Pharmaceutical Development, Approval and Manufacturing...
read more»Breakthrough Cost Improvement Service...
read more»"Validation and Six Sigma" Article in Medical Device Technology Europe Nov 2008...
read more»Integrating Operational Excellence and Risk Management Approaches; Tools for Achieving Breakthrough in Economic Medical Device Manufacturing...
read more»HACCP - Medical Device Risk Management - UK Dates 13-14 November - NEC Birmingham...
read more»Pharmaceutical Risk Managment: HACCP...
read more»Medical Device Quality System Design Control Master Class...
read more»Key Success Factors in Six Sigma Deployments...
read more»Pharmaceutical Quality Control Risk Managment & Operational Excellence...
read more»